Noreen A. Reilly-Harrington
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Noreen A. Reilly-Harrington has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Michael W. Otto
Boston University
32 shared publications - Aude Henin
Clinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital, Boston, MA, USA
31 shared publications - Gary S. Sachs
Bipolar Clinic and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
31 shared publications - Jane Null Kogan
UPMC Insurance Services Division and UPMC Center for High‐Value Health Care Pittsburgh Pennsylvania USA
31 shared publications Robert O. Knauz
31 shared publications- Louisa G. Sylvia
Dauten Family Center for Bipolar Treatment Innovation, Department of Psychiatry, Massachusetts General Hospital, 50 Staniford Street, Suite 580, Boston, MA, 02114, United States; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, United States
4 shared publications
Latest Publications
- 12 December 2024
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 149, 107777
Ketamine treatment in youth for fast reduction of suicidality and engagement in psychotherapy: A randomized placebo-controlled trial protocol
- 12 December 2024
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 149, 107777
Ketamine treatment in youth for fast reduction of suicidality and engagement in psychotherapy: A randomized placebo-controlled trial protocol
- Open Access
Barriers to Care for Pediatric Patients with Obesity
This review article emphasizes the challenges pediatric patients face during obesity treatment. Prior research has been compartmentalized, acknowledging that stigma, the ability to implement lifestyle changes, social health determinants, and healthcare accessibility are considerable impediments for obese children. These issues emerge at various levels, including the individual or family, the community and school, and even national policy. This suggests the need for a more comprehensive, team-based approach to tackle pediatric obesity. Understanding these barriers is the first step toward creating effective strategies and solutions to overcome these challenges.
Open AccessBarriers to Care for Pediatric Patients with Obesity
This review article emphasizes the challenges pediatric patients face during obesity treatment. Prior research has been compartmentalized, acknowledging that stigma, the ability to implement lifestyle changes, social health determinants, and healthcare accessibility are considerable impediments for obese children. These issues emerge at various levels, including the individual or family, the community and school, and even national policy. This suggests the need for a more comprehensive, team-based approach to tackle pediatric obesity. Understanding these barriers is the first step toward creating effective strategies and solutions to overcome these challenges.
- 1 August 2021
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 140, 205-213
Illness stage and predominant polarity in bipolar disorder: Correlation with burden of illness and moderation of treatment outcome
- 1 August 2021
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 140, 205-213
Illness stage and predominant polarity in bipolar disorder: Correlation with burden of illness and moderation of treatment outcome
- 27 October 2018
- Published by Springer Nature in Current Obesity Reports
- Vol. 7 (4) , 294-300
Bipolar Disorder and Obesity: Contributing Factors, Impact on Clinical Course, and the Role of Bariatric Surgery
Bipolar disorder (BD) is a severe, common, and chronic affective disorder. This review highlights the BD and obesity connection and the role of treatments for obesity in this population.
- 27 October 2018
- Published by Springer Nature in Current Obesity Reports
- Vol. 7 (4) , 294-300
Bipolar Disorder and Obesity: Contributing Factors, Impact on Clinical Course, and the Role of Bariatric Surgery
Bipolar disorder (BD) is a severe, common, and chronic affective disorder. This review highlights the BD and obesity connection and the role of treatments for obesity in this population.
- Open Access
- 27 March 2017
- Published by Springer Nature in International Journal of Bipolar Disorders
- Vol. 5 (1) , 1-8
Poor quality of life and functioning in bipolar disorder
Background: This study explores the association of demographic and clinical features with quality of life and functioning in individuals with bipolar disorder. Methods: Adult participants (N = 482) with bipolar I or II disorder were enrolled in a comparative effectiveness study across eleven study sites and completed baseline measures of medical and psychiatric history, current mood, quality of life, and functioning. Participants with at least mildly depressive or manic/hypomanic symptomatic severity were randomized to receive lithium or quetiapine in addition to adjunctive personalized treatment for 6 months. Results: Participants with more severe depressive and irritability symptoms had lower quality of life and higher functional impairment. All psychiatric comorbid conditions except substance use disorder were associated with worse quality of life. On average, females had lower quality of life than males. Patients who were married, living as married, divorced, or separated had worse functional impairment compared with patients who were single or never married. A composite score of social disadvantage was associated with worse functioning and marginally associated with worse quality of life. Symptom severity did not moderate the effect of social disadvantage on quality of life or functioning. Conclusions: Our findings highlight that depression, irritability, and psychiatric comorbid conditions negatively impact quality of life and functioning in bipolar disorder. The study suggests that individuals with social disadvantage are at risk for functional impairment. Trial Registration This study is registered with ClinicalTrials.gov. Identification number: NCT01331304
- 27 March 2017
- Published by Springer Nature in International Journal of Bipolar Disorders
- Vol. 5 (1) , 1-8
Open AccessPoor quality of life and functioning in bipolar disorder
Background: This study explores the association of demographic and clinical features with quality of life and functioning in individuals with bipolar disorder. Methods: Adult participants (N = 482) with bipolar I or II disorder were enrolled in a comparative effectiveness study across eleven study sites and completed baseline measures of medical and psychiatric history, current mood, quality of life, and functioning. Participants with at least mildly depressive or manic/hypomanic symptomatic severity were randomized to receive lithium or quetiapine in addition to adjunctive personalized treatment for 6 months. Results: Participants with more severe depressive and irritability symptoms had lower quality of life and higher functional impairment. All psychiatric comorbid conditions except substance use disorder were associated with worse quality of life. On average, females had lower quality of life than males. Patients who were married, living as married, divorced, or separated had worse functional impairment compared with patients who were single or never married. A composite score of social disadvantage was associated with worse functioning and marginally associated with worse quality of life. Symptom severity did not moderate the effect of social disadvantage on quality of life or functioning. Conclusions: Our findings highlight that depression, irritability, and psychiatric comorbid conditions negatively impact quality of life and functioning in bipolar disorder. The study suggests that individuals with social disadvantage are at risk for functional impairment. Trial Registration This study is registered with ClinicalTrials.gov. Identification number: NCT01331304
- 19 November 2016
- Published by Springer Nature
- p. 37-63
Cognitive-Behavioral Management of Obesity
- 4 July 2016
- Published by Elsevier in Journal of Affective Disorders
- Vol. 205, 159-164
Tracking medication changes to assess outcomes in comparative effectiveness research: A bipolar CHOICE study
- 4 July 2016
- Published by Elsevier in Journal of Affective Disorders
- Vol. 205, 159-164
Tracking medication changes to assess outcomes in comparative effectiveness research: A bipolar CHOICE study
- 1 March 2016
- Published by Elsevier in Journal of Affective Disorders
- Vol. 192, 212-218
A tool to predict suicidal ideation and behavior in bipolar disorder: The Concise Health Risk Tracking Self-Report
- 1 March 2016
- Published by Elsevier in Journal of Affective Disorders
- Vol. 192, 212-218
A tool to predict suicidal ideation and behavior in bipolar disorder: The Concise Health Risk Tracking Self-Report
- 27 January 2016
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 77 (01) , 100-108
Baseline Disability and Poor Functioning in Bipolar Disorder Predict Worse Outcomes
To examine the effects of treatment on functioning impairments and quality of life and assess baseline functioning and employment status as predictors of treatment response in symptomatic individuals from the Bipolar Clinical Health Outcomes Initiative in Comparative Effectiveness (Bipolar CHOICE) study. Bipolar CHOICE was an 11-site, 6-month randomized effectiveness study comparing lithium to quetiapine, each with adjunctive personalized treatments (APTs). We examined post hoc (1) the effects of treatment on functioning, (2) how changes in functioning differed between treatment responders and nonresponders, and (3) whether functioning and employment status mediated treatment response in 482 participants with DSM-IV-TR bipolar I or II disorder from September 2010 to September 2013. Treatment was associated with significant improvements in functioning and quality of life, regardless of treatment group (P values < .0001). Responders showed greater improvements in quality of life (Quality of Life Enjoyment and Satisfaction Questionnaire P values < .05) and functioning (Longitudinal Interval Follow-up Evaluation-Range of Impaired Functioning Tool P values < .05) than nonresponders. Unemployed or disabled participants at baseline had significantly greater illness severity at baseline than employed participants (P values < .05). Over the study duration, employed participants reported greater improvements in physical health and quality of life in leisure activities than both unemployed and disabled participants (P values < .05). Individuals who saw greater improvement in functioning and quality of life tended to show greater improvements in depressive and anxiety symptoms (P values ≤ .0001), as well as overall illness severity (P values < .001). Early (8 weeks) and very early (4 weeks) clinical changes in mood symptoms predicted changes in functioning and quality of life at 6 months (P values < .001). Prior disability status was associated with a worse treatment response and prospective illness course. Results implicate functioning and employment status as important markers of illness severity and likelihood of recovery in bipolar disorder, suggesting that interventions that target functional impairment may improve outcomes. ClinicalTrials.gov identifier for the Bipolar CHOICE study: NCT01331304.
- 27 January 2016
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 77 (01) , 100-108
Baseline Disability and Poor Functioning in Bipolar Disorder Predict Worse Outcomes
To examine the effects of treatment on functioning impairments and quality of life and assess baseline functioning and employment status as predictors of treatment response in symptomatic individuals from the Bipolar Clinical Health Outcomes Initiative in Comparative Effectiveness (Bipolar CHOICE) study. Bipolar CHOICE was an 11-site, 6-month randomized effectiveness study comparing lithium to quetiapine, each with adjunctive personalized treatments (APTs). We examined post hoc (1) the effects of treatment on functioning, (2) how changes in functioning differed between treatment responders and nonresponders, and (3) whether functioning and employment status mediated treatment response in 482 participants with DSM-IV-TR bipolar I or II disorder from September 2010 to September 2013. Treatment was associated with significant improvements in functioning and quality of life, regardless of treatment group (P values < .0001). Responders showed greater improvements in quality of life (Quality of Life Enjoyment and Satisfaction Questionnaire P values < .05) and functioning (Longitudinal Interval Follow-up Evaluation-Range of Impaired Functioning Tool P values < .05) than nonresponders. Unemployed or disabled participants at baseline had significantly greater illness severity at baseline than employed participants (P values < .05). Over the study duration, employed participants reported greater improvements in physical health and quality of life in leisure activities than both unemployed and disabled participants (P values < .05). Individuals who saw greater improvement in functioning and quality of life tended to show greater improvements in depressive and anxiety symptoms (P values ≤ .0001), as well as overall illness severity (P values < .001). Early (8 weeks) and very early (4 weeks) clinical changes in mood symptoms predicted changes in functioning and quality of life at 6 months (P values < .001). Prior disability status was associated with a worse treatment response and prospective illness course. Results implicate functioning and employment status as important markers of illness severity and likelihood of recovery in bipolar disorder, suggesting that interventions that target functional impairment may improve outcomes. ClinicalTrials.gov identifier for the Bipolar CHOICE study: NCT01331304.
- 1 June 2015
- Published by Oxford University Press (OUP)
- p. 445-454
Family-Focused Therapy, Interpersonal and Social Rhythm Therapy, and Dialectical Behavioral Therapy
- 1 June 2015
- Published by Oxford University Press (OUP)
- p. 445-454
Family-Focused Therapy, Interpersonal and Social Rhythm Therapy, and Dialectical Behavioral Therapy